Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The emperor’s new isodose curves
1.C. Thieke, A. Niemierko, T. Bortfeld, and S. Nill, “From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning,” Med. Phys. 30, 2332–2339 (2003).
2.M. J. Zelefsky, Z. Fuks, M. Hunt, Y. Yamada, C. Marion, C. C. Ling, H. Amols, E. S. Venkatraman, and S. A. Leibel, “High-dose intensity modu-lated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients,” Int. J. Radiat. Oncol., Biol., Phys. 53, 1111–1116 (2002).
3.D. B. Chism, E. M. Horwitz, A. L. Hanlon, W. H. Pinover, R. K. Mitra, and G. E. Hanks, “Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement,” Int. J. Radiat. Oncol., Biol., Phys. 55, 71–77 (2003).
4.B. D. Kavanagh, T. E. Schefter, Q. Wu, S. Tong, F. Newman, M. Arnfield, S. H. Benedict, S. McCourt, and R. Mohan, “Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer,” Semin. Radiat. Oncol. 12, 260–271 (2002).
Article metrics loading...